Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Investor Overview

Corporate Profile

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

PRESS RELEASES More »

Toggle Summary Stryker to host analyst meeting
Kalamazoo, Michigan - October 4, 2018 - Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 8, 2018 , at 2:30 p.m. Eastern Time , in Mahwah, New Jersey.  A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at
Toggle Summary Stryker acquires HyperBranch Medical Technology, Inc.
Kalamazoo, Michigan - October 1, 2018 - Stryker (NYSE:SYK) announced today the acquisition of privately-held HyperBranch Medical Technology, Inc. for a total equity value of approximately $220 million in an all cash transaction. HyperBranch is dedicated to developing medical devices based on its
Toggle Summary Stryker to host conference call on October 25, 2018
Kalamazoo, Michigan - September 20, 2018 - Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 25, 2018 at 4:30 p.m., Eastern Time , to discuss the Company's operating results for the quarter ended September 30, 2018 and provide an operational update.
Toggle Summary Stryker announces definitive agreement to acquire Invuity, Inc.
Kalamazoo, Michigan - September 11, 2018 - Stryker (NYSE: SYK) announced today a definitive agreement to acquire all the issued and outstanding shares of common stock of Invuity, Inc. (NASDAQ: IVTY) for $7.40 per share, or a total equity value of approximately $190 million .
Investor Contacts
Katherine A. Owen
Vice President, Strategy & Investor Relations
Stryker
2825 Airview Boulevard
Kalamazoo, MI 49002
269-385-2600